FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Animals (Basel) / Modulation of Serum Protein Electrophoretic Pattern and Leuk...
Animals : an open access journal from MDPI2021; 11(2); 477; doi: 10.3390/ani11020477

Modulation of Serum Protein Electrophoretic Pattern and Leukocyte Population in Horses Vaccinated against West Nile Virus.

Abstract: This study aimed to evaluate the hematological and serum protein electrophoretic profiles of horses after inactivated West Nile virus (WNV) vaccine administration. Blood samples were collected from 10 horses before (T0), after 24 h, 48 h, 72 h, 1 week, 2 weeks and 3 weeks (T1, T2, T3, T4, T5 and T6) from the first WNV vaccine-dose administration, before the vaccine-booster (TPRE), and after 24 h, 48 h, 72 h, 1 week, 2 weeks and 3 weeks (T1, T2, T3, T4, T5, T6) from the WNV vaccine-booster. There was a significant increase in lymphocytes and a decrease in neutrophils after both the first vaccine-dose and vaccine-booster administration compared to the baseline values ( < 0.01). Monocytes showed higher values after 72 h, 1 week and 2 weeks from the vaccine-booster ( < 0.01). Higher serum total protein values were found in horses after both the first vaccine-dose and booster administration ( < 0.05). α1-lobulins increased after the vaccine-booster with the highest levels measured at T4 ( < 0.05); α-2- and β-globulin fractions increased throughout the post-vaccine period compared to the baseline values ( < 0.05); and higher γ-globulin values were found before the vaccine-booster (TPRE) and after 24 h, 72 h and 3 weeks from the vaccine-booster (T1, T3 and T6). The findings allow us to conclude that the WNV vaccine used in the current study does not alter the overall hemogram picture of horses although it is associated with modulation of leukocyte populations and the serum protein electrophoretic pattern.
Get Full Text
Publication Date: 2021-02-11 PubMed ID: 33670395PubMed Central: PMC7918827DOI: 10.3390/ani11020477Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study investigates the effects of a West Nile Virus (WNV) vaccine on horses, specifically observing the hematological and serum protein electrophoretic profiles. The researchers found that the vaccine did not overall alter the horses’ blood profiles, but there were specific changes to white blood cell populations and protein levels after both the initial vaccination and booster shot.

Study Overview

  • The study included 10 horses and observed the changes in their blood profiles over different periods after they received an inactivated WNV vaccine and a booster shot. The duration for observation included 24 hours, 48 hours, 72 hours, 1 week, 2 weeks, and 3 weeks after both the initial and booster vaccinations.

Impact on Leukocyte Population

  • There was a significant increase in lymphocytes, a type of white blood cell that helps fight off infections, after both the initial vaccine dose and booster shot in comparison to the baseline values.
  • Neutrophils, another type of white blood cell usually an immediate responder to inflammation, decreased after both vaccine doses.
  • Monocytes, the largest type of white blood cells and which typically become macrophages and facilitate immune response against viruses and bacteria, showed higher values specifically after 72 hours, 1 week and 2 weeks from the time the booster was given.

Impact on Serum Protein Electrophoretic Profile

  • There were higher total protein values found in the horses’ blood after both the initial vaccine dose and booster administration.
  • Specific proteins such as α1-lobulins increased after the vaccine booster, with the highest levels measured one week after administration.
  • Similarly, alpha-2- and beta-globulin fractions also increased throughout the post-vaccine period compared to the baseline values. These globulins are associated with transporting lipids and fat-soluble vitamins in the blood.
  • Gamma globulin values, proteins that function as antibodies, were higher before the booster dose and again at specific intervals after the booster (24 hours, 72 hours and 3 weeks).

Conclusion

  • Ultimately, the study concluded that while the WNV vaccine used did not broadly alter the overall hemogram (complete blood count) of the horses, it did have specific impacts on the leukocyte populations and the serum protein electrophoretic pattern. This suggests some immune system modulation occurred following both the initial WNV vaccination and the subsequent booster shot.

Cite This Article

APA
Arfuso F, Giudice E, Di Pietro S, Piccione G, Giannetto C. (2021). Modulation of Serum Protein Electrophoretic Pattern and Leukocyte Population in Horses Vaccinated against West Nile Virus. Animals (Basel), 11(2), 477. https://doi.org/10.3390/ani11020477

Publication

Animals : an open access journal from MDPI
ISSN: 2076-2615
NlmUniqueID: 101635614
Country: Switzerland
Language: English
Volume: 11
Issue: 2
PII: 477

Researcher Affiliations

Arfuso, Francesca
  • Department of Veterinary Sciences, Polo Universitario dell'Annunziata, University of Messina, 98168 Messina, Italy.
Giudice, Elisabetta
  • Department of Veterinary Sciences, Polo Universitario dell'Annunziata, University of Messina, 98168 Messina, Italy.
Di Pietro, Simona
  • Department of Veterinary Sciences, Polo Universitario dell'Annunziata, University of Messina, 98168 Messina, Italy.
Piccione, Giuseppe
  • Department of Veterinary Sciences, Polo Universitario dell'Annunziata, University of Messina, 98168 Messina, Italy.
Giannetto, Claudia
  • Department of Veterinary Sciences, Polo Universitario dell'Annunziata, University of Messina, 98168 Messina, Italy.

Conflict of Interest Statement

The authors declare no conflict of interest.

References

This article includes 42 references
  1. European Centre for Disease Prevention and Control. Weekly updates: 2020 West Nile Virus Transmission Season. 2020.
  2. Calzolari M, Pautasso A, Montarsi F, Albieri A, Bellini R, Bonilauri P, Defilippo F, Lelli D, Moreno A, Chiari M, Tamba M, Zanoni M, Varisco G, Bertolini S, Modesto P, Radaelli MC, Iulini B, Prearo M, Ravagnan S, Cazzin S, Mulatti P, Monne I, Bonfanti L, Marangon S, Goffredo M, Savini G, Martini S, Mosca A, Farioli M, Gemma Brenzoni L, Palei M, Russo F, Natalini S, Angelini P, Casalone C, Dottori M, Capelli G. West Nile Virus Surveillance in 2013 via Mosquito Screening in Northern Italy and the Influence of Weather on Virus Circulation.. PLoS One 2015;10(10):e0140915.
    doi: 10.1371/journal.pone.0140915pmc: PMC4619062pubmed: 26488475google scholar: lookup
  3. Young JJ, Coulombier D, Domanović D, Zeller H, Gossner CM. One Health approach for West Nile virus surveillance in the European Union: relevance of equine data for blood safety.. Euro Surveill 2019 Apr;24(16).
    doi: 10.2807/1560-7917.ES.2019.24.16.1800349pmc: PMC6826348pubmed: 31014416google scholar: lookup
  4. Calistri P, Giovannini A, Hubalek Z, Ionescu A, Monaco F, Savini G, Lelli R. Epidemiology of west nile in europe and in the mediterranean basin.. Open Virol J 2010 Apr 22;4:29-37.
    doi: 10.2174/1874357901004010029pmc: PMC2878979pubmed: 20517490google scholar: lookup
  5. Pisani G, Cristiano K, Pupella S, Liumbruno GM. West Nile Virus in Europe and Safety of Blood Transfusion.. Transfus Med Hemother 2016 May;43(3):158-67.
    doi: 10.1159/000446219pmc: PMC4924479pubmed: 27403087google scholar: lookup
  6. Kramer LD, Li J, Shi PY. West Nile virus.. Lancet Neurol 2007 Feb;6(2):171-81.
    doi: 10.1016/S1474-4422(07)70030-3pubmed: 17239804google scholar: lookup
  7. Saegerman C, Alba-Casals A, García-Bocanegra I, Dal Pozzo F, van Galen G. Clinical Sentinel Surveillance of Equine West Nile Fever, Spain.. Transbound Emerg Dis 2016 Apr;63(2):184-93.
    doi: 10.1111/tbed.12243pubmed: 24899369google scholar: lookup
  8. Cantile C, Di Guardo G, Eleni C, Arispici M. Clinical and neuropathological features of West Nile virus equine encephalomyelitis in Italy.. Equine Vet J 2000 Jan;32(1):31-5.
    doi: 10.2746/042516400777612080pubmed: 10661382google scholar: lookup
  9. Saiz JC. Animal and Human Vaccines against West Nile Virus.. Pathogens 2020 Dec 21;9(12).
    doi: 10.3390/pathogens9121073pmc: PMC7767344pubmed: 33371384google scholar: lookup
  10. Fiacre L, Pagès N, Albina E, Richardson J, Lecollinet S, Gonzalez G. Molecular Determinants of West Nile Virus Virulence and Pathogenesis in Vertebrate and Invertebrate Hosts.. Int J Mol Sci 2020 Nov 30;21(23).
    doi: 10.3390/ijms21239117pmc: PMC7731113pubmed: 33266206google scholar: lookup
  11. Diamond MS, Shrestha B, Mehlhop E, Sitati E, Engle M. Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus.. Viral Immunol 2003;16(3):259-78.
    doi: 10.1089/088282403322396082pubmed: 14583143google scholar: lookup
  12. Diamond MS, Pierson TC, Fremont DH. The structural immunology of antibody protection against West Nile virus.. Immunol Rev 2008 Oct;225:212-25.
    doi: 10.1111/j.1600-065X.2008.00676.xpmc: PMC2646609pubmed: 18837784google scholar: lookup
  13. Pierson TC. Waste not, want not: a viral RNA degradation product modulates west nile virus pathogenesis.. Cell Host Microbe 2008 Dec 11;4(6):512-3.
    doi: 10.1016/j.chom.2008.11.004pubmed: 19064251google scholar: lookup
  14. Samuel MA, Diamond MS. Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion.. J Virol 2006 Oct;80(19):9349-60.
    doi: 10.1128/JVI.01122-06pmc: PMC1617273pubmed: 16973541google scholar: lookup
  15. Mills PC, Auer DE, Kramer H, Barry D, Ng JC. Effects of inflammation-associated acute-phase response on hepatic and renal indices in the horse.. Aust Vet J 1998 Mar;76(3):187-94.
    doi: 10.1111/j.1751-0813.1998.tb10126.xpubmed: 9578755google scholar: lookup
  16. Andersen SA, Petersen HH, Ersbøll AK, Falk-Rønne J, Jacobsen S. Vaccination elicits a prominent acute phase response in horses.. Vet J 2012 Feb;191(2):199-202.
    doi: 10.1016/j.tvjl.2011.01.019pubmed: 21371917google scholar: lookup
  17. Carson PJ, Prince HE, Biggerstaff BJ, Lanciotti R, Tobler LH, Busch M. Characteristics of antibody responses in West Nile virus-seropositive blood donors.. J Clin Microbiol 2014 Jan;52(1):57-60.
    doi: 10.1128/JCM.01932-13pmc: PMC3911469pubmed: 24131687google scholar: lookup
  18. Long MT, Gibbs EP, Mellencamp MW, Bowen RA, Seino KK, Zhang S, Beachboard SE, Humphrey PP. Efficacy, duration, and onset of immunogenicity of a West Nile virus vaccine, live Flavivirus chimera, in horses with a clinical disease challenge model.. Equine Vet J 2007 Nov;39(6):491-7.
    doi: 10.2746/042516407X217416pubmed: 18065305google scholar: lookup
  19. Long MT, Gibbs EP, Mellencamp MW, Zhang S, Barnett DC, Seino KK, Beachboard SE, Humphrey PP. Safety of an attenuated West Nile virus vaccine, live Flavivirus chimera in horses.. Equine Vet J 2007 Nov;39(6):486-90.
    doi: 10.2746/042516407X214473pubmed: 18065304google scholar: lookup
  20. European Centre for Disease Prevention and Control. West Nile virus risk assessment tool. 2013.
  21. Weiss DJ, Wardrop KJ. Schalm’s Veterinary Hematology. 2010.
  22. Kaneko JJ. Clinical Biochemistry of Domestic Animals. 1989 pp. 142–165.
  23. Piccione G, Fazio F, Giudice E, Grasso F, Morgante M. Nycthemeral change of some haematological parameters in horses. J. Appl. Biomed. 2005;3:123–128.
    doi: 10.32725/jab.2005.015google scholar: lookup
  24. Piccione G, Assenza A, Fazio F, Giudice E, Caola G. Different periodicities of some haematological parameters in exercise-loaded athletic horses and sedentary horses. J. Equine. Sci. 2001;12:17–23.
    doi: 10.1294/jes.12.17google scholar: lookup
  25. Piccione G, Arfuso F, Marafioti S, Giannetto C, Giudice E, Fazio F. Different training schedules influence serum electrophoretic protein profile in the athletic horse. J. Equine. Vet. Sci. 2015;35:856–859.
    doi: 10.1016/j.jevs.2015.08.008google scholar: lookup
  26. Minke JM, Siger L, Karaca K, Austgen L, Gordy P, Bowen R, Renshaw RW, Loosmore S, Audonnet JC, Nordgren B. Recombinant canarypoxvirus vaccine carrying the prM/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge.. Arch Virol Suppl 2004;(18):221-30.
    pubmed: 15119777doi: 10.1007/978-3-7091-0572-6_20google scholar: lookup
  27. Murphy BR, Chanock RM. Immunization against viral diseases. Fields Virology 2001 4th ed. Volume 1 pp. 435–468.
  28. Siger L, Bowen RA, Karaca K, Murray MJ, Gordy PW, Loosmore SM, Audonnet JC, Nordgren RM, Minke JM. Assessment of the efficacy of a single dose of a recombinant vaccine against West Nile virus in response to natural challenge with West Nile virus-infected mosquitoes in horses.. Am J Vet Res 2004 Nov;65(11):1459-62.
    doi: 10.2460/ajvr.2004.65.1459pubmed: 15566080google scholar: lookup
  29. Monaco F, Purpari G, Di Gennaro A, Mira F, Di Marco P, Guercio A, Savini G. Immunological response in horses following West Nile virus vaccination with inactivated or recombinant vaccine.. Vet Ital 2019 Mar 31;55(1):73-79.
    pubmed: 30951184
  30. Goundasheva D, Chenchev I, Katsarova R, Karadjov T, Tsachev I, Barzev G. Changes in leukocyte and antibody response following exercise in horses with booster vaccination against influenza and equine herpes virus 4/1. Revue. Méd. Vét. 2005;156:527–532.
  31. Ahlers LRH, Goodman AG. The Immune Responses of the Animal Hosts of West Nile Virus: A Comparison of Insects, Birds, and Mammals.. Front Cell Infect Microbiol 2018;8:96.
    doi: 10.3389/fcimb.2018.00096pmc: PMC5891621pubmed: 29666784google scholar: lookup
  32. Chaintoutis SC, Diakakis N, Papanastassopoulou M, Banos G, Dovas CI. Evaluation of Cross-Protection of a Lineage 1 West Nile Virus Inactivated Vaccine against Natural Infections from a Virulent Lineage 2 Strain in Horses, under Field Conditions.. Clin Vaccine Immunol 2015 Sep;22(9):1040-9.
    doi: 10.1128/CVI.00302-15pmc: PMC4550672pubmed: 26178384google scholar: lookup
  33. Jain NC. Essentials of Veterinary Hematology. 1993 p. 417.
  34. Ravel R. Proteínas séricas. 1997 6th ed. Volume 22 p. 616.
  35. Naoum PC. Eletroforese—técnicas e diagnóstico. 1999 p. 154.
  36. Jacobsen S, Niewold TA, Halling-Thomsen M, Nanni S, Olsen E, Lindegaard C, Andersen PH. Serum amyloid A isoforms in serum and synovial fluid in horses with lipopolysaccharide-induced arthritis.. Vet Immunol Immunopathol 2006 Apr 15;110(3-4):325-30.
    doi: 10.1016/j.vetimm.2005.10.012pubmed: 16337010google scholar: lookup
  37. Jacobsen S, Nielsen JV, Kjelgaard-Hansen M, Toelboell T, Fjeldborg J, Halling-Thomsen M, Martinussen T, Thoefner MB. Acute phase response to surgery of varying intensity in horses: a preliminary study.. Vet Surg 2009 Aug;38(6):762-9.
    doi: 10.1111/j.1532-950X.2009.00564.xpubmed: 19674420google scholar: lookup
  38. Jacobsen S, Thomsen MH, Nanni S. Concentrations of serum amyloid A in serum and synovial fluid from healthy horses and horses with joint disease.. Am J Vet Res 2006 Oct;67(10):1738-42.
    doi: 10.2460/ajvr.67.10.1738pubmed: 17014325google scholar: lookup
  39. Jacobsen S, Kjelgaard-Hansen M, Hagbard Petersen H, Jensen AL. Evaluation of a commercially available human serum amyloid A (SAA) turbidometric immunoassay for determination of equine SAA concentrations.. Vet J 2006 Sep;172(2):315-9.
    doi: 10.1016/j.tvjl.2005.04.021pubmed: 15950503google scholar: lookup
  40. Fehér O, Bakonyi T, Barna M, Nagy A, Takács M, Szenci O, Joó K, Sárdi S, Korbacska-Kutasi O. Serum neutralising antibody titres against a lineage 2 neuroinvasive West Nile Virus strain in response to vaccination with an inactivated lineage 1 vaccine in a European endemic area.. Vet Immunol Immunopathol 2020 Sep;227:110087.
    doi: 10.1016/j.vetimm.2020.110087pubmed: 32629300google scholar: lookup
  41. Davidson AH, Traub-Dargatz JL, Rodeheaver RM, Ostlund EN, Pedersen DD, Moorhead RG, Stricklin JB, Dewell RD, Roach SD, Long RE, Albers SJ, Callan RJ, Salman MD. Immunologic responses to West Nile virus in vaccinated and clinically affected horses.. J Am Vet Med Assoc 2005 Jan 15;226(2):240-5.
    doi: 10.2460/javma.2005.226.240pubmed: 15706975google scholar: lookup
  42. Kutzler MA, Baker RJ, Mattson DE. Humoral response to West Nile virus vaccination in alpacas and llamas.. J Am Vet Med Assoc 2004 Aug 1;225(3):414-6.
    doi: 10.2460/javma.2004.225.414pubmed: 15328718google scholar: lookup

Citations

This article has been cited 3 times.
  1. Riccò M, Zaniboni A, Satta E, Ranzieri S, Cerviere MP, Marchesi F, Peruzzi S. West Nile Virus Infection: A Cross-Sectional Study on Italian Medical Professionals during Summer Season 2022.. Trop Med Infect Dis 2022 Nov 28;7(12).
    doi: 10.3390/tropicalmed7120404pubmed: 36548659google scholar: lookup
  2. Desanti-Consoli H, Bouillon J, Chapuis RJJ. Equids' Core Vaccines Guidelines in North America: Considerations and Prospective.. Vaccines (Basel) 2022 Mar 4;10(3).
    doi: 10.3390/vaccines10030398pubmed: 35335029google scholar: lookup
  3. Riccò M, Peruzzi S, Balzarini F. Public Perceptions on Non-Pharmaceutical Interventions for West Nile Virus Infections: A Survey from an Endemic Area in Northern Italy.. Trop Med Infect Dis 2021 Jun 29;6(3).
    doi: 10.3390/tropicalmed6030116pubmed: 34209481google scholar: lookup
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.